AnubisMed
- Product NDC
- 83021-774
- 11-digit product format
- 830210774
- Labeler code
- 83021
- Product ID
- 83021-774_eb04d402-e750-6281-e053-2995a90a5ef3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aloe Barbadensis Leaf Extract, Propylene Glycol, Cetearyl Ethylhexanoate
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- ANUBIS COSMETICS SL
- Application
- M016
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-10-14
- Marketing end
- 0000-00-00
- Substance
- 1,2-HEXANEDIOL; ALLANTOIN; ALOE VERA LEAF; ARGAN OIL; BUTYLATED HYDROXYTOLUENE; BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES; C12-20 ACID PEG-8 ESTER; CAPRYLYL GLYCOL; CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; DECYL OLEATE; FRAGRANCE 13576; GLYCERIN; GRAPE SEED OIL; HEXAMETHYLENE DIISOCYANATE/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER; IMIDUREA; MEDIUM-CHAIN TRIGLYCERIDES; PROPYLENE GLYCOL; SILICON DIOXIDE; TOCOPHEROL; TROLAMINE; TROPOLONE; WATER
- Active strength
- 0 g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; g/15mL; mL/15mL
- Pharmacologic classes
- Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 83021-774 | D | Discontinued by firm | 2026-10-20 | ||
| excluded package | package | 83021-774 | 83021-774-15 | D | Discontinued by firm | 2026-10-20 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 83021-774-15 | 83021077415 | 15 mL in 1 TUBE (83021-774-15) | 15 ml | 2022-10-14 | 0000-00-00 | No | No | Current |